Levemir’s Sunset: A New Dawn in Diabetes Care
Summary Novo Nordisk will discontinue Levemir insulin by the end of 2026. This decision prompts a shift in diabetes management, emphasizing patient transition to alternative therapies. This article explores the discontinuation, its implications, and the […]
